Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
General Notices
- Notice of Pre-Application Webinar for Funding Opportunities RFA-AG-24-030 and RFA-AG-24-031
(NOT-AG-23-053)
National Institute on Aging
- Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-24-320 and RFA-MH-24-322
(NOT-MH-23-390)
National Institute of Mental Health
- Notice to Rescind NOT-OD-21-027 "Notice of Clarification of SB1 Resubmission/Submission Policy"
(NOT-OD-23-184)
National Institutes of Health
- Findings of Research Misconduct
(NOT-OD-23-186)
Office of the Director, NIH
- Findings of Research Misconduct
(NOT-OD-23-187)
Office of the Director, NIH
- Notice of Upcoming Prize Competition Announcement for the Complement-Animal Research in Experimentation (Complement-ARIE) Challenge
(NOT-RM-23-025)
Office of Strategic Coordination (Common Fund)
- Request for Information (RFI): Identifying Opportunities to Generate Research Molecular Characterization Data for the Childhood Cancer Data Initiative (CCDI)
(NOT-CA-23-093)
National Cancer Institute
- NINR Request for Information (RFI): Advancing Nursing Research in Climate and Health
(NOT-NR-23-018)
National Institute of Nursing Research
- Request for Information (RFI): Inviting Input on NCATS Strategic Plan for 2024-2029
(NOT-TR-23-027)
National Center for Advancing Translational Sciences
Notice of Changes to Funding Opportunities
- Notice of Participation of the National Institute on Aging (NIA) in RFA-NS-24-024, "Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)"
(NOT-AG-23-049)
National Institute on Aging
- Notice of Early Expiration of "Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation", NOT-AI-22-072
(NOT-AI-23-062)
National Institute of Allergy and Infectious Diseases
- Notice of Need to Expire and Reissue of RFA-MH-24-160, RFA-MH-24-161 and RFA-MH-24-162 "Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (Clinical Trial Optional R01, R21 and R34)"
(NOT-MH-23-380)
National Institute of Mental Health
- Notice of Clarification of NIMH Research Priorities for RFA-ES-23-007 "Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)"
(NOT-MH-23-385)
National Institute of Mental Health
- Notice of Change in the Expiration Date for PAR-21-228, "NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)"
(NOT-MH-23-395)
National Institute of Mental Health
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
(NOT-NS-24-008)
National Institute of Neurological Disorders and Stroke
Notices of Special Interest
- Notice of Special Interest (NOSI):?Advancing Data Science Research in HIV: Responding to a Dynamic, Complex, and Evolving HIV Epidemic with Artificial Intelligence/Machine Learning
(NOT-MH-23-350)
National Institute of Mental Health
Funding Opportunities
- Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
(PAR-23-284)
National Cancer Institute
National Institute of Dental and Craniofacial Research - Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
(PAR-23-296)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health - Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
(PAR-23-297)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health - Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)
(PAR-23-305)
National Institute of Mental Health - Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional)
(PAR-23-307)
National Institute of Mental Health - NIDA REI: Training a Diverse Data Science Workforce for Addiction Research (R25 Clinical Trial Not Allowed)
(RFA-DA-24-025)
National Institute on Drug Abuse - NIDA REI: Academic Research Enhancement Award (AREA) Training a Diverse Data Science Workforce for Addiction Research (R15 Clinical Trial Not Allowed)
(RFA-DA-24-026)
National Institute on Drug Abuse - HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
(RFA-DA-24-066)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Aging
Office of Behavioral and Social Sciences Research
Office of Disease Prevention - HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional)
(RFA-DA-24-067)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Aging
Office of Behavioral and Social Sciences Research
Office of Disease Prevention - Single Source: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)
(RFA-DA-25-015)
National Institute on Drug Abuse - Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional (R01 Clinical Trial Not Allowed)
(RFA-DA-25-016)
National Institute on Drug Abuse - Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional (R21 Clinical Trial Not Allowed)
(RFA-DA-25-017)
National Institute on Drug Abuse - BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
(RFA-EY-23-001)
National Eye Institute
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research - Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R01 Clinical Trial Optional)
(RFA-MH-24-330)
National Institute of Mental Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of AIDS Research
Office of Research on Women's Health - Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional)
(RFA-MH-24-331)
National Institute of Mental Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of AIDS Research
Office of Research on Women's Health - Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional)
(RFA-MH-24-332)
National Institute of Mental Health
Office of AIDS Research
Office of Research on Women's Health
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail)(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail)(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail)(link sends e-mail).